Intrathecal Pertussis Toxin but not Cyclic AMP Blocks Kappa Opioid-Induced Antinociception in rat

References

• Attali B., Saya D., Vogel Z. K‐opiate agonists inhibit adenylate cyclase and produce heterologous de‐sensitization in rat spinal cord. Journal of Neurochemistry 1989; 52: 360–369
   PubMed Web of Science ®Google Scholar
• Attali B., Saya D., Nah S. Y., Vogel Z. K opiate agonists inhibit Ca2+ influx in rat spinal cord‐dorsal root ganglion cocultures. Journal of Biological Chemistry 1989; 264: 347–353
   PubMedGoogle Scholar
• Brown A. M., Birnbaumer L. Ionic channels and their regulation by G protein subunits. Annual Reviews of Physiology 1990; 52: 197–213
   PubMed Web of Science ®Google Scholar
• Chang H. M., Berde C. B., Holz G. G., Steward G. F., Kream R. M. Sufentanil, morphine, met‐enkephalin, and K‐agonist (U‐50,488H) inhibit substance P release from primary sensory neurons: A model for presynaptic spinal opioid actions. Anesthesiology 1989; 70: 672–677
   PubMedGoogle Scholar
• Crain S. M., Crain B., Makman M. H. Pertussis toxin blocks depressant effects of opioid, monoamin‐ergic and muscarinic agonists on dorsal‐horn network responses in spinal cord‐ganglion cultures. Brain Research 1987; 400: 185–190
   PubMedGoogle Scholar
• Dong X., Parsons C. G., Headley P. M. Effects of intravenous μ and K opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats. British Journal of Pharmacology 1991; 103: 1230–1236
   PubMed Web of Science ®Google Scholar
• Duggan A. W., Griersmith B. T. Methyl xanthines, adenosine 3′,5′‐cyclic monophosphate and the spinal transmission of nociceptive information. British Journal of Pharmacology 1979; 67: 51–57
   PubMedGoogle Scholar
• Fleetwood‐Walker S. M., Hope P. J., Mitchell R., El‐Yassir N., Molony V. The influence of opioid receptor subtypes on the processing of nociceptive inputs in the spinal dorsal horn of the cat. Brain Research 1988; 451: 213–226
   PubMedGoogle Scholar
• Hernandez A., Paeile C., Perez H., Pelissier T., Soto‐Moyano R. K‐opioid receptor mediated depression of activity evoked in convergent dorsal horn cells by thermal and nonthermal noxious stimulation. European Journal of Pharmacology 1990; 186: 323–325
   PubMed Web of Science ®Google Scholar
• Hescheler J., Rosenthal W., Trautwein W., Schultz G. The GTP binding protein, Go, regulates neu‐ronal calcium channels. Nature 1987; 325: 445–447
   PubMed Web of Science ®Google Scholar
• Ho I. K., Loh H. H., Way E. L. Effects of cyclic 3′.5′‐adenosine monophosphate on morphine tolerance and physical dependence. Journal of Pharmacology and Experimental Therapeutics 1973; 185: 347–357
   PubMedGoogle Scholar
• Kurose H., Katada T., Amano T., Ui M. Specific uncoupling by islet‐activating protein, pertussis toxin, of negative signal transduction via α‐adrenergic. cholinergic and opiate receptors in neuroblastoma x glioma hibrid cells. Journal of Biological Chemistry 1983; 258: 4870–4875
   PubMed Web of Science ®Google Scholar
• MacDonald R. L., Werz M. A. Dynorphin A decreases voltage‐dependent calcium conductance of mouse dorsal root ganglion neurons. Journal of Physiology 1986; 377: 237–249
   PubMedGoogle Scholar
• McFadzean I. The ionic mechanisms underlying opioid actions. Neuropeptides 1988; II: 173–180
   Google Scholar
• Mestre C., Pelissier T., Wilcox G. L., Eschalier A., Lavarenne J. Intrathecal administration of drugs in unanesthetized rats: technical and pharmacological aspects. In International Association for the Study of Pain. Proceedings of 7th World Congress on Pain. IASP Publications, Seattle 1993; 77
   Google Scholar
• Millan M. J., Czlonkowski A., Herz A. CNS K‐opioid receptors mediate antinociception against both pressure and thermal but not electrical stimuli in the rat. Advances in the Biosciences, Vol. 75, Progress in Opioid Research, J. Cross, J. ‐C. Meunier, M. Hamon. Pergamon Press, Oxford 1989; 459–462
   Google Scholar
• Murray C. W., Cowan A. Tonic pain perception in the mouse: differential modulation by three receptor‐selective opioid agonists. Journal of Pharmacology and Experimental Therapeutics 1991; 257: 335–341
   PubMedGoogle Scholar
• Nakazawa T., Yamanishi Y., Kaneko T. A comparative study of monoaminergic involvement in the antinociceptive action of E‐2078, morphine and U‐50,488E. Journal of Pharmacology and Experimental Therapeutics 1991; 257: 748–753
   PubMedGoogle Scholar
• Parenti M., Tirone F., Giagnoni G., Pecora N., Parolaro D. Pertussis toxin inhibits the antinociceptive action of morphine in the rat. European Journal of Pharmacology 1986; 124: 357–361
   PubMedGoogle Scholar
• Przewlocki R., Costa T., Lang J., Herz A. Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord. European Journal of Pharmacology 1987; 144: 91–95
   PubMedGoogle Scholar
• Shen K. F., Crain S. M. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Research 1989; 491: 227–242
   PubMed Web of Science ®Google Scholar
• Sterweis P. C., Pang L. H. The G protein‐channel connection. Trends in Neuroscience 1990; 13: 122–126
   PubMedGoogle Scholar
• Tseng L. F., Collins K. A. Involvement of epsilon and kappa opioid receptors in inhibition of the tail‐flick response induced by bremazocine in the mouse. Journal of Pharmacology and Experimental Therapeutics 1991; 259: 330–336
   PubMedGoogle Scholar
• Werz M. A., MacDonald R. L. Dynorphin reduces calcium‐dependent action potentials by decreasing voltage‐dependent calcium conductance. Neuroscience Letters 1984; 46: 185–190
   PubMedGoogle Scholar